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A large French family including members affected by nonspeciﬁc X-linked mental retardation, with or without
autism or pervasive developmental disorder in affected male patients, has been found to have a 2–base-pair deletion
in the Neuroligin 4 gene (NLGN4) located at Xp22.33. This mutation leads to a premature stop codon in the
middle of the sequence of the normal protein and is thought to suppress the transmembrane domain and sequences
important for the dimerization of neuroligins that are required for proper cell-cell interaction through binding to
b-neurexins. As the neuroligins are mostly enriched at excitatory synapses, these results suggest that a defect in
synaptogenesis may lead to deﬁcits in cognitive development and communication processes. The fact that the deletion
was present in both autistic and nonautistic mentally retarded males suggests that the NLGN4 gene is not only
involved in autism, as previously described, but also in mental retardation, indicating that some types of autistic
disorder and mental retardation may have common genetic origins.
X-linked mental retardation (XLMR) is a highly het-
erogeneous condition, including 1140 distinct disorders
and affecting ∼1.6/1,000 males, with a carrier frequency
of 2.4/1,000 females (Herbst andMiller 1980; Stevenson
and Schwartz 2002). Two groups have been deﬁned:
nonspeciﬁc forms (MRX), in which mental retardation
(MR) is the only clinical manifestation, and syndromic
forms (MRXS), in which MR is associated with recog-
nizable physical signs such as skeletal abnormalities or
dysmorphic facial features (Chelly and Mandel 2001).
Both MRX and MRXS genes have been located at var-
ious regions of the X chromosome (Chiurazzi et al.
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2001). To date, it is estimated that at least 30 genes are
involved in MRX, but only 14 have been isolated.
Autism is a neurodevelopmental disorder beginning
before the age of 3 years and characterized by severe
social and communication impairments, repetitive and
ritualistic behaviors, and a restricted pattern of interests
(American Psychiatric Association 1994). The preva-
lence of autism is estimated at ∼10/10,000 when broader
deﬁnitions are used (Fombonne 2003). Many studies,
including correlation in twins and association of autism
with Mendelian diseases, have supported a genetic eti-
ology for this condition. Nevertheless, autism appears
to be clinically and genetically heterogeneous, suggesting
that multiple loci are involved (Risch et al. 1999). The
male/female sex ratio for autism is estimated at 4:1
(Fombonne 2003), and several genome screens have
shown that at least two loci on the X chromosome are
associated with a predisposition to autism—that is,
Xp22.3 and Xq13-21 (Philippe et al. 1999; Auranen et
al. 2002). The report of a de novo chromosomal deletion
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Figure 1 Pedigree of family T118. The diagram shows the 13 males who were identiﬁed as having nonspeciﬁc MR (blackened squares),
nonspeciﬁc MR with autism (diagonally striped squares), or pervasive developmental disorder (gray square). For eight subjects, diagnoses were
made by direct examination or from medical records, and the ﬁve other males were institutionalized. A minus sign () above a symbol indicates
that a blood sample was obtained for analysis.
at Xp22.3 in three unrelated autistic females (Thomas
et al. 1999) and a nonsense mutation recently found in
the Neuroligin 4 (NLGN4) gene in a family with two
non–mentally retarded brothers with autism and As-
perger syndrome (MIM 300427) respectively (Jamain et
al. 2003), suggest that this gene could be involved in
autistic disorders.
Wide intra- and extrafamilial phenotype heterogeneity
exists in MRX conditions. Mild-to-severe MR and as-
sociation with psychiatric disorders such as autism is
frequently reported. MR is present in ∼70% of individ-
uals with autism, and in half of these individuals intel-
lectual quotient (IQ) is evaluated as !50 (Fombonne
2002). Among 25 French families including 135 male
patients withMRX135, we found 7 families with at least
one mentally retarded male with autistic disorder, ac-
cording to criteria of the Diagnostic and StatisticalMan-
ual of Mental Disorders, 4th edition (DSM-IV [Ameri-
can Psychiatric Association 1994]). Fragile X syndrome
(FRAXA) was excluded, and diagnosis of isolated MR
orMR associated with autistic symptomswasmade after
examination of the patients (Gomot et al., unpublished
data).
We present here the molecular and clinical data of one
of these families (family T118) in which we found a null
mutation in the NLGN4 gene in autistic and nonautistic
mentally retarded males. The pedigree of the family is
shown in ﬁgure 1. In this family, 13 males have been
identiﬁed as having autism, MR, or pervasive develop-
mental disorder; for eight subjects, this diagnosis was
based on direct medical examination or on their medical
records (table 1). Interviews of the nonaffected family
members conﬁrmed that the other subjects were insti-
tutionalized and that one of them was killed in a road
accident (individual III-8).
Patient IV-10 was aged 8 years 1 mo at the time of
the clinical evaluation by a child psychiatrist and by a
psychologist. He met diagnostic criteria for autistic
disorder (DSM-IV [American Psychiatric Association
1994]). Diagnostic evaluation also included the Autism
Diagnostic Interview—Revised (ADI [Lord et al. 1994]).
His ADI scores were 13 in the social domain (cutoffp
8), 13 in the language (verbal) domain (cutoffp 8), and
4 in the repetitive/restrictive behaviors domain (cutoffp
3). Developmental abnormalities were identiﬁed before
36 mo of age. Developmental ages for the Vineland
Adaptative Behavior Scale (Sparrow et al. 1985) were 3
years 2 mo, for communication, 3 years 10 mo, for daily
living skills, 2 years 9 mo, for socialization, and 4 years
11 mo, for motor skills. The intellectual assessment was
made using the age-appropriate Wechsler Preschool
and Primary Scale of Intelligence—Revised (WPPSI-R
[Wechsler 1989]), providing verbal and performance IQs
of 37 and 88, respectively, and an overall IQ of 62, which
led to an associated diagnosis of mild MR. Physical ex-
amination revealed normal growth parameters with no
discernible dysmorphic features, except for posterior
plagiocephaly. Electroencephalogram (EEG) and mor-
phometric MRI results showed no abnormalities. Late
auditory evoked potentials with mismatch-negativity
paradigm showed a typical proﬁle for children with au-
tism (Gomot et al. 2002).
His mother (III-14), a 34-year-old obligate carrier, was
tested with the Wechsler Adult Intelligence Scale—III
(WAIS-III [Wechsler 1997]) and had a verbal IQ of 90,
a performance IQ of 105, and an overall IQ of 96. Her
subscore in nonverbal analogic treatment indicated re-
tardation, with a developmental age of 10 years.
Patients III-3 and III-11 were 44 and 42 years of age,
respectively, when they were examined (using the WAIS-
III) by a psychiatrist with experience of working with
children and adults with developmental disorders. They
met DSM-IV criteria for MR without an associated psy-
chiatric disorder. Patient III-3 had mildMRwith a verbal
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Table 1
Summary of Clinical Findings
FINDING IN SUBJECT
CHARACTERISTICS
Male
Affected
Unaffected,
IV-9
Female,
III-14III-2a III-3 III-4a III-7a IV-3a III-11 IV-7a IV-10 III-15 IV-14a III-27a IV-23
Age at examination (years) NA 44 NA NA NA 42 11 8 30 NA NA 16 13 34
Dysmorphic features No Plagiocephaly ND ND ND No ND Plagiocephaly No ND ND No No No
Intelligence ND Mild MR ND ND ND Subnormal ND Mild MR Subnormal ND ND Subnormal Normal Normal
Autism ND No ND ND ND No Yes Yes No No No No
IQ:
Total ND 63 ND ND ND 77 ND 62 72 ND ND 74 142 96
Verbal ND 70 ND ND ND 82 ND 37 79 ND ND 76 127 90
Performance ND 60 ND ND ND 75 ND 88 63 ND ND 75 141 105
NOTE.—NA p not available; ND p not determined.
a Institutionalized patient.
IQ of 70, a performance IQ of 60, and an overall IQ of
63. Patient III-11 had subnormal intelligence with a ver-
bal IQ of 82, a performance IQ of 75, and an overall
IQ of 77. Patient III-11 had no dysmorphic features. He
had a head trauma injury at the age of 4 years that
resulted in coma for 6 d. Patient III-3 presented posterior
plagiocephaly. His work environment was adapted for
mentally handicapped adults. Patient III-4 declined psy-
chiatric examination but was admitted to a psychiatric
unit for aggressive behavior at the time of his brother’s
clinical interview.
Clinical information on patient III-15, a 30-year-old
man, was taken from an interview with his mother and
from his medical records. He was born after three mis-
carriages. Delivery was normal. He experienced hy-
poxic-ischemic events in the ﬁrst weeks of life, with ep-
ileptic seizures from 1 to 9 years of age. Psychomotor
development was retarded, and he could sit alone at the
age of 2 years. He was tested with the WAIS-III and had
subnormal intelligence with a verbal IQ of 79, a per-
formance IQ of 63, and an overall IQ of 72. He receives
an allowance for mentally handicapped adults. He is
friendly and sociable.
Clinical information on patient IV-23 was taken from
medical records. At the age of 2.5 years, he was admitted
to a children’s psychiatric unit. He was identiﬁed as hav-
ing pervasive developmental disorder, not otherwise
speciﬁed (PDD-NOS). He was 16 years of age when he
was assessed with the Weschler Adult Intelligence
Scale—Revised (WAIS-R [Wechsler 1981]), and he had
a verbal IQ of 76, a performance IQ of 75, and an overall
IQ of 74. He also presented transient tic disorder and
received neuroleptic treatment. The only available med-
ical information concerning patient IV-7, an 11-year-old
boy, is that his condition was diagnosed as autism in a
children’s psychiatric unit.
In family T118, two-point linkage analysis by use of
41 DNA markers spanning the X chromosome indicated
a strong linkage of XLMR to Xp21.2-pter, with a max-
imum LOD score of 3.30 ( ) for DXS996 andvp 0
DXS989. Several previously isolated MRX genes fall
within the linkage interval, such as RSK2 (Merienne et
al. 1999), IL1RAPL (Carrie et al. 1999), VCX (Fukami
et al. 2000), and ARX (Bienvenu et al. 2002; Stromme
et al. 2002). Furthermore, the report of de novo Xp
deletions in three females with autism (Thomas et al.
1999) and the description of a susceptibility locus at
DXS996 (Philippe et al. 1999) suggested that a gene
involved in autistic disorder was located at Xpter. A gene
encoding for a member of the neuroligin family, named
“Neuroligin 4” (NLGN4 or KIAA1260), has recently
been mapped to Xp22.33 (obtained from the Ensembl
Genome Browser) and closely linked to DXS996 (Bol-
liger et al. 2001), and a mutation was found in two
brothers with autism and Asperger syndrome, bothwith-
out MR (Jamain et al. 2003).
We sequenced this gene in the members of family T118
for whom genomic DNAwas available (ﬁg. 1). After PCR
analysis of the coding exons, the products were directly
sequenced. We detected a 2-bp deletion, nt1253del(AG)
(GenBank accession numbers: NM_020742, AF376803),
in the ﬁfth exon of NLGN4 in all affected patients (ﬁg.
2a). This deletion caused a frameshift in the coding se-
quence and was predicted to create a stop codon at po-
sition 429 (ﬁg. 2b). The healthy males did not carry the
deletion, and the obligate carrier females were heterozy-
gous for the mutation. We did not observe this deletion
in 200 healthy male controls, and analysis of the X-chro-
mosome inactivation proﬁle in the obligate carrier females
was not informative. The resulting mutated protein is pre-
dicted to be truncated by ∼50% of its normal sequence
(429 amino acids, instead of 816) and to lose the C-
terminal transmembrane domain.
We also screened for mutations of this gene in eight
families collected by the European XLMR consortium
with MRX overlapping Xp22.33 regions and DXS996
(including family MRX49 [Claes et al. 1997] and seven
small families with two affected brothers), but we failed
Figure 2 Identiﬁcation of the NLGN4 mutation in family T118. A, Schematic representation of the organization of the NLGN4 gene
and representative NLGN4 sequence of normal, affected, and heterozygous subjects from family T118. PCR products of each coding exon
(from 100 ng of DNA) were ampliﬁed (primers and PCR conditions available on request), puriﬁed through Sephadex G-50 columns, and
analyzed by agarose-gel electrophoresis. The products were then sequenced using the ABI PRISM BigDye Terminator Sequencing Kit (PE Applied
Biosystems) on an ABI PRISM 377 automated sequencer. The arrows mark the position of the NLGN4 mutation (cDNA nucleotide 1253). B,
Sequence alignments between the normal and the predicted mutated NLGN4 proteins. The position of the mutation and the consequence on
the amino acid sequence are indicated in red. C, Schematic representation of the NLGN4 protein with the predicted constitutive domains by
homology with the other neuroligins. The region of dimerization is positioned at the base of the AchE domain and would be absent in the
truncated NLGN4.
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to detect any variations in the coding sequence. The
other families with MRX and autism were not screened
for the NLGN4 gene because their linkage area did not
fall in Xp22.33.
Jamain et al. (2003) recently reported a nonsense mu-
tation in NLGN4 that led to a predicted truncated pro-
tein of 396 amino acids in a Swedish family with two
affected brothers who exhibited autism or Asperger syn-
drome, both without MR. Our study showed the in-
volvement of the same gene in XLMR with or without
autism. Altogether, these results suggest that mutations
in NLGN4 are involved in a wide spectrum of pheno-
types, ranging from mild isolated MR without com-
munication deﬁcits (family T118) to Asperger syndrome
with normal or supranormal intelligence (Jamain et al.
2003). The phenotypic heterogeneity of this X-linked
condition suggests that the expression of the mutation
is modulated by genetic or nongenetic factors.
The NLGN4 gene belongs to the neuroligin family
made up of neuronal cell-surface proteins located in the
synaptic structures. They are composed of a large ex-
tracellular noncatalytic acetylcholinesterase homology
domain, which is required for presynaptic neurexin
binding, a transmembrane domain, and a short cyto-
plasmic tail with a postsynaptic density 95-disc large
zona-occludens-1 (PDZ) binding domain (ﬁg. 2). They
are particularly abundant in the postsynaptic membrane
of glutamatergic synapses, suggesting speciﬁc targeting
to excitatory synapses (Song et al. 1999).
Experiments in vitro have shown that the intercellular
neuroligin-neurexin adhesion complex is able to trigger
formation of functional presynaptic elements and leads
to axon specialization (Scheiffele et al. 2000). As the
neuroligin C-terminus binds the postsynaptic proteins
PSD-95 and S-SCAM that link neuroligins to NMDA
receptors and downstream signal-transducing proteins,
the neuroligin-neurexin interaction may also mediate
postsynaptic differentiation (Rao et al. 2000).
A previous study has shown that oligomerization of
neuroligins is required for their activity in synaptoge-
nesis. Dean et al. (2003) demonstrated that two alpha
helices located at the base of the AchE-homologous do-
main of NLGN1 were critical for interaction between
other neuroligins, with inactivating amino acid muta-
tions that affect multimerization and reduce the synapse-
promoting activity of the protein.
Although these experiments were performedwith con-
structs from the Neuroligin 1 gene that shares 71.2%
identity with NLGN4 in their amino acid sequences, we
can expect that the mutated NLGN4 protein will lack
structural elements indispensable for its speciﬁc activity.
Indeed, the sequence homology between NLGN1 and
NLGN4 and the position of the mutation in NLGN4 in
family T118 indicates that these regions, which are im-
portant for oligomerization, were deleted, thus poten-
tially leading to a loss of synaptogenic activity (ﬁg. 2c).
In summary, we report a new gene involved in XLMR,
which is also associated with autism and pervasive de-
velopmental disorder. Moreover, this gene has also been
reported to be involved in autism and Asperger syn-
drome without MR, suggesting strong phenotypic het-
erogeneity. We propose that NLGN4 deﬁciency in the
brain may lead to abnormal development of synaptic
structures and may have dramatic effects on commu-
nication processes and cognitive development. The gen-
eration of animal models with null mutations of this
gene would provide an approach to the functional con-
sequences of such a deﬁciency.
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